As of June 03, 2025, Adverum Biotechnologies (ADVM) has a market cap of $52.436 million USD. According to our data, Adverum Biotechnologies is ranked No.8107 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jun 03, 2025 | $52.44 M |
-46.25%
|
Dec 31, 2024 | $97.56 M |
-37.98%
|
Dec 29, 2023 | $0.16 B |
29.83%
|
Dec 30, 2022 | $0.12 B |
-67.05%
|
Dec 31, 2021 | $0.37 B |
-83.76%
|
Dec 31, 2020 | $2.26 B |
-5.90%
|
Dec 31, 2019 | $2.41 B |
265.71%
|
Dec 31, 2018 | $0.66 B |
-10.00%
|
Dec 29, 2017 | $0.73 B |
20.69%
|
Dec 30, 2016 | $0.61 B |
-69.54%
|
Dec 31, 2015 | $1.99 B |
-82.37%
|
Dec 31, 2014 | $11.28 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() REGENXBIO
RGNX
|
$0.51 B |
0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.15 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.29 B |
0.000 M
|
![]() Switzerland
|
![]() bluebird bio
BLUE
|
$48.67 M |
0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$3.82 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.79 B |
-0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() Agios Pharmaceuticals
AGIO
|
$1.94 B |
0.000 M
|
![]() USA
|
![]() PTC Therapeutics
PTCT
|
$4.01 B |
0.000 M
|
![]() USA
|
![]() Boundless Bio
BOLD
|
$25.07 M |
0.000 M
|
![]() USA
|
![]() Voyager Therapeutics
VYGR
|
$0.18 B |
0.000 M
|
![]() USA
|
Market Cap | = | ADVM Stock Price | * | ADVM Shares Outstanding |
= | $2.51 | * | 20.89 M | |
= | $52.44 M |